Cytoskeletal alterations in the aged human neurohypophysis

Neuroscience Letters

Volumn 237, Issue 2-3, 1997, Pages 93-96

  Schultz, Christian ^a   Koppers, Dagmar ^a   Braak, Heiko ^a   Braak, Eva ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Abnormal phosphorylation; Alzheimer's disease; Paraventricular nucleus; Pituitary gland; Supraoptic nucleus; Tau protein

Indexed keywords

TAU PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NEUROHYPOPHYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID; CYTOSKELETON; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLES; PITUITARY GLAND, POSTERIOR; TAU PROTEINS;

EID: 0031438691     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00817-3     Document Type: Article

References (14)

1. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seitelberger F., Grundke-Iqbal I., Wisniewski H.M. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99.
2. Biernat J., Gustke N., Drewes G., Mandelkow E.M., Mandelkow E. Phosphorylation of serine 262 strongly reduces the binding of tau protein to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 11:1993;153-163.
3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
4. Braak H., Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1:1991;213-216.
5. Braak E., Braak H., Mandelkow E.M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87:1994;554-567.
6. Campbell S.K., Switzer R.C., Martin T.L. Alzheimer's plaques and tangles: a controlled and enhanced silver-staining method. Soc. Neurosci. Abstr. 13:1987;678.
7. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 19:1971;1-8.
8. Greenberg S.G., Davies P., Schein J.D., Binder L.I. Hydrofluoric acid-treated tau/PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267:1992;564-569.
9. McKinley, M.J. and Oldfield, B.J., Circumventricular organs. In G. Paxinos (Ed.), The Human Nervous System, Academic Press, New York, 1990, pp. 415-438.
10. Mercken M., Vandermeeren M., Lübke U., Six J., Boons J., Van de Voorde A., Martin J.J., Gheuens J. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. 84:1992;265-272.
11. Schultz C., Braak H., Braak E. A sex difference in neurodegeneration of the human hypothalamus. Neurosci. Lett. 212:1996;103-106.
12. Schultz C., Ghebremedhin E., Braak H., Braak E. Neurofibrillary pathology in the human paraventricular and supraoptic nuclei. Acta Neuropathol. 94:1997;99-102.
13. Swaab, D.F., Neurobiology and neuropathology of the human hypothalamus. In F.E. Bloom, A. Björklund and T. Hökfelt (Eds.), Handbook of Chemical Neuroanatomy: The Primate Nervous System, Part I, Elsevier, Amsterdam, Vol. 13, 1997, pp. 39-136.
14. Wolozin B.L., Pruchnicki A., Dickson D.W., Davies P. A neuronal antigen in the brains of Alzheimer patients. Science. 232:1986;648-650.